Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Novick

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of Biopharmaceutical Statistics|September 19, 2023
Whole-cage randomization for animal studies with unequal cage or group sizesTianhui Zhang, Benjamin Phillips, Natasha Karp, et al.
Pharmaceutical Statistics|November 26, 2019
Comparisons of outlier tests for potency bioassaysPerceval Sondag, Lingmin Zeng, Binbing Yu, et al.
ACS Chemical Neuroscience|August 4, 2012
A simple method for quantifying functional selectivity and agonist biasTerry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
Journal of Biopharmaceutical Statistics|October 31, 2014
Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statisticSteven Novick, Yan Shen, Harry Yang, et al.
Pharmaceutical Statistics|August 17, 2018
Effect of a statistical outlier in potency bioassaysPerceval Sondag, Lingmin Zeng, Binbing Yu, et al.
Cancer Chemotherapy and Pharmacology|October 17, 2012
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteersOphelia Q P Yin, Véronique Bédoucha, Tracey McCulloch, et al.
Pharmaceutical Statistics|October 7, 2020
The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA-BIOP Nonclinical Bayesian Working GroupPaul Faya, Perceval Sondag, Steven Novick, et al.
Journal of Clinical Pharmacology|November 25, 2014
Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolamHefei Zhang, Jennifer Sheng, Jin H Ko, et al.
Pharmaceutical Statistics|September 24, 2024
Quality by Design for Preclinical In Vitro Assay DevelopmentJonathan Jones, Bairu Zhang, Xiang Zhang, et al.
AAPS Pharmscitech|January 18, 2014
Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effectHefei Zhang, Binfeng Xia, Jennifer Sheng, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of Biopharmaceutical Statistics|September 19, 2023
Whole-cage randomization for animal studies with unequal cage or group sizesTianhui Zhang, Benjamin Phillips, Natasha Karp, et al.
Pharmaceutical Statistics|November 26, 2019
Comparisons of outlier tests for potency bioassaysPerceval Sondag, Lingmin Zeng, Binbing Yu, et al.
ACS Chemical Neuroscience|August 4, 2012
A simple method for quantifying functional selectivity and agonist biasTerry Kenakin, Christian Watson, Vanessa Muniz-Medina, et al.
Journal of Biopharmaceutical Statistics|October 31, 2014
Dissolution curve comparisons through the F(2) parameter, a Bayesian extension of the f(2) statisticSteven Novick, Yan Shen, Harry Yang, et al.
Pharmaceutical Statistics|August 17, 2018
Effect of a statistical outlier in potency bioassaysPerceval Sondag, Lingmin Zeng, Binbing Yu, et al.
Cancer Chemotherapy and Pharmacology|October 17, 2012
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteersOphelia Q P Yin, Véronique Bédoucha, Tracey McCulloch, et al.
Pharmaceutical Statistics|October 7, 2020
The current state of Bayesian methods in nonclinical pharmaceutical statistics: Survey results and recommendations from the DIA/ASA-BIOP Nonclinical Bayesian Working GroupPaul Faya, Perceval Sondag, Steven Novick, et al.
Journal of Clinical Pharmacology|November 25, 2014
Inhibitory effect of single and repeated doses of nilotinib on the pharmacokinetics of CYP3A substrate midazolamHefei Zhang, Jennifer Sheng, Jin H Ko, et al.
Pharmaceutical Statistics|September 24, 2024
Quality by Design for Preclinical In Vitro Assay DevelopmentJonathan Jones, Bairu Zhang, Xiang Zhang, et al.
AAPS Pharmscitech|January 18, 2014
Application of physiologically based absorption modeling to formulation development of a low solubility, low permeability weak base: mechanistic investigation of food effectHefei Zhang, Binfeng Xia, Jennifer Sheng, et al.
Pageof 4